Search Results: PARP inhibitor

• Health & Medicine
• Science & Technology

Unpicking the genetic ‘patchwork’ in ovarian cancer

Our researchers are investigating the genetic 'patchwork' underlying ovarian tumours, which will lead to more effective treatments in the future. Our researchers are investigating the genetic 'patchwork' underlying ovarian tumours, which will lead to more effective treatments in the future.

12 March 2015

• Health & Medicine
• Science & Technology

Pushing ‘unstable’ pancreatic cancers over the edge

We look at fascinating new research from our scientists showing that pancreatic cancer can be split into four different types. We look at fascinating new research from our scientists showing that pancreatic cancer can be split into four different types.

26 February 2015

• Science & Technology

Lethal Weapon Too: Using DNA repair processes to target cancer

A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes. A Lethal Weapon against cancer? Researchers are using ‘synthetic lethality’ to develop new treatments based on targeting DNA repair processes.

24 February 2015

• Health & Medicine
• Science & Technology

News digest - Government science funding, exercise and prostate cancer, drug approval and more

Government science funding announcement, exercise and prostate cancer, plus a handful of stories about drug approval - here’s the week’s cancer news. Government science funding announcement, exercise and prostate cancer, plus a handful of stories about drug approval - here’s the week’s cancer news.

20 December 2014

• Science & Technology

NCRI 2014 conference summary - day 4

Here's our final round-up from the 2014 NCRI cancer conference in Liverpool Here's our final round-up from the 2014 NCRI cancer conference in Liverpool

6 November 2014

• Health & Medicine
• Science & Technology

NCRI 2014 conference summary - day 3

Here’s our round up from day three of the NCRI cancer conference in Liverpool. Here’s our round up from day three of the NCRI cancer conference in Liverpool.

5 November 2014

• Science & Technology
• Health & Medicine

NCRI 2014 conference summary - day 1

Here's our round up from day one of the NCRI cancer conference in Liverpool Here's our round up from day one of the NCRI cancer conference in Liverpool

3 November 2014

• Science & Technology

It’s time to be positive about triple negative breast cancer

Triple negative breast cancer has poorer survival and is less well understood than other types, but research is making a difference. Triple negative breast cancer has poorer survival and is less well understood than other types, but research is making a difference.

30 June 2014

• Health & Medicine

Experimental breast cancer drug to be trialled in lung cancer patients

A clinical trial using an experimental drug originally designed to treat breast cancer launches for patients with advanced lung cancer  A clinical trial using an experimental drug originally designed to treat breast cancer launches for patients with advanced lung cancer 

11 March 2014

• Health & Medicine
• Science & Technology

News digest – genetic breakthrough, new skin cancer drug, neuroblastoma trial, and more

This week's big cancer news stories included research into cancer's genetic fingerprint, skin cancer drug approval, a childhood brain tumour trial and more. This week's big cancer news stories included research into cancer's genetic fingerprint, skin cancer drug approval, a childhood brain tumour trial and more.

16 August 2013

Experimental drugs for breast cancer could treat lung cancer too

Scientists have discovered that experimental drugs first developed for breast and ovarian cancer could be used to treat lung cancer. Scientists have discovered that experimental drugs first developed for breast and ovarian cancer could be used to treat lung cancer.

12 August 2013